Opens in a new tab
Gabrail Research — Part of PhaseWell Oncology

Clinical Trials at
Gabrail Research.

Expanding treatment options for eligible patients — while continuing care with the physicians and care team they already know and trust.

Physician-led clinical research
Research integrated with patient care
Supported by PhaseWell Oncology

Is a clinical trial right for me?

Clinical trials may offer eligible patients access to investigational therapies, closer monitoring, and a way to contribute to future advances in cancer care. Whether one is right for you is a decision made together with your physician.

Meet one-on-one with Dr. Gabrail for a complimentary 15-minute consultation. You’ll have the opportunity to discuss your diagnosis, ask questions about clinical trials, and determine whether a research study may be an appropriate option for you.

By clicking the “Schedule Your Complimentary 15-Minute Consultation” button below, you confirm that, to the extent consent is required by law, you consent to Gabrail Cancer Center Research’s storage, use, and disclosure of the information you provide when scheduling your consultation to determine your potential eligibility for studies that Gabrail Cancer Center Research conducts or may conduct, to contact you about such studies, and for other purposes described in our Privacy Notice. You can revoke your consent by contacting us at info@phasewell.com. Gabrail Cancer Center Research does not guarantee that you will be notified of all studies for which you might be eligible, or that you will participate in any of the studies that you are contacted about. You are under no obligation to participate in any study. Please review our Privacy Notice for more information about how we handle personal data.

Schedule Your Complimentary 15-Minute Consultation

What We Consider Together

Your diagnosis, cancer type and stage
Previous treatments
Study-specific eligibility criteria
Biomarkers or test results
Current health and medical history
Your personal preferences

Cancer Type

Find a Clinical Trial

Search current research opportunities.

Our research team can help determine whether a study may be appropriate based on your diagnosis, treatment history, and eligibility.

Not sure where to begin? Read our clinical trials FAQ, or speak with a research coordinator.

Show More Trials

Frequently Asked Questions

Everything you may want to know about clinical trials.

What patients ask before deciding, answered here.

Gabrail Cancer Center provides comprehensive medical oncology and hematology services for patients diagnosed with all types of cancer and blood disorders.

Every treatment plan is personalized to your diagnosis, health history and goals, ensuring you receive the care that’s right for you. 

A clinical trial is a research study that helps physicians evaluate new treatments, medications, and approaches to cancer care. Every study follows strict medical, ethical, and regulatory guidelines designed to protect participants while advancing future treatment options. Participation is always voluntary, made together with your physician and care team, and choosing not to participate does not affect your regular care.

Trials are conducted in four phases, each serving a different purpose. The phase number doesn’t mean a study is automatically better or worse for you individually.

  • Phase I evaluates the safest dose of a promising new treatment while closely monitoring side effects.
  • Phase II studies how well a treatment works against a specific type of cancer while continuing to evaluate safety.
  • Phase III compares a new treatment with today’s standard treatment in larger groups of patients.
  • Phase IV monitors FDA-approved treatments over time to better understand long-term safety and effectiveness.

The research team will explain each study in detail before you decide — including what is known, what remains uncertain, and what to expect.

  • Potential benefits may include access to investigational therapies, close physician supervision and comprehensive monitoring, and helping advance cancer research for future patients.
  • Potential considerations may include possible side effects, additional appointments or testing, travel or time requirements, the treatment not being effective for you, and risks that may not yet be fully known.

This depends on the specific study design. Your research coordinator and physician will explain exactly how a given study is structured before you decide whether to participate.

Yes. Participation is voluntary, and you may choose to stop at any time. Leaving a study does not affect your regular care.

Costs generally fall into a few categories: research-related costs that may be covered by the study sponsor, routine care costs that may be billed to insurance as usual, and any travel or personal expenses you may want to plan for. Coverage varies by study, so our research and financial teams will review the specifics with you before you decide. Ask about study costs.

Yes. Many patients choose to involve family members in conversations with the research team and physician while deciding whether to participate.

Your physician and research team monitor your progress closely throughout the study and will discuss options with you if a treatment isn’t working as hoped.

Time commitments vary by study — some require additional visits or monitoring. Your research coordinator will explain what to expect for any study you’re considering.

Your research coordinator and physician are your primary points of contact and can answer questions at any stage of the process.

Patient Research Stories

Hear from patients who 
chose clinical research.

Every patient’s experience with clinical research is unique. 
These stories reflect how participation became part of a personalized treatment plan, while allowing patients to continue receiving care from the physicians and care team they already knew and trusted.

About PhaseWell Research

World-class research, rooted in community.

PhaseWell Research is a wholly owned, investigator-led multisite clinical research company. The company partners with sponsors and CROs to support Phase I–IV clinical trials across complex, high-demand therapeutic areas.

Rooted in the communities it serves, PhaseWell expands access to advanced clinical research for patients who may otherwise have limited opportunities to participate.

Visit PhaseWell Research

Are you a sponsor or CRO looking to place a study?

Learn more about our approach to study start-up, patient access, and quality on PhaseWell’s website.

Explore Sponsor & CRO Resources

Have a question about clinical research?

Talk with our research team.

(330) 492-3345 or (330) 844-5500
Talk With a Research Coordinator